Pierre Thadee Victor Kemula insider trades

Open-market stock purchases and sales by Pierre Thadee Victor Kemula, Chief Financial Officer at AgomAb Therapeutics NV, from SEC Form 4 filings since Oct 6, 2026.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +8%.

Recent trades

DateStockTradeValue
Oct 6, 2026AGMB AgomAb Therapeutics NVBought$26K
Oct 6, 2026AGMB AgomAb Therapeutics NVBought$42.9K
Oct 6, 2026AGMB AgomAb Therapeutics NVBought$17.1K

Companies traded

  • AGMB AgomAb Therapeutics NV: 3 buys, last Oct 6, 2026

Get free alerts when Pierre Thadee Victor Kemula files a new trade →